BE1116
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BE1116, covering 2025-11-10 to 2025-11-10. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of BE1116 in Patients With Traumatic Injury and Acute Major Bleeding to Improve Survival ( TAP Study ) [Phase 3]